Researcher.Life Logo

British Journal of General Practice : Impact Factor & More

eISSN: 1478-5242pISSN: 0960-1643

Aims and Scope of British Journal of General Practice

The British Journal of General Practice is a monthly peer-reviewed medical journal for general practitioners and primary care researchers.

Key Metrics

CiteScore
4.2
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Family Practice
SNIP
1.68
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on British Journal of General Practice

British Journal of General Practice Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ROYAL COLL GENERAL PRACTITIONERS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1990
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in British Journal of General Practice ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in British Journal of General Practice

Safety and Efficacy of Inhaled Natural Product Powders That Enhance Mucociliary Clearance.
  • 15 May 2026
  • AAPS PharmSciTech
Effects of Different Carriers on the Stability and Pharmacokinetic Performance of Cucurbitacin B Solid Dispersions.
  • 15 May 2026
  • AAPS PharmSciTech
In vitro Evaluation of Hydroxypropyl-β-cyclodextrin Effects on Rhein Flux Across Microneedle-pretreated Skin.
  • 15 May 2026
  • AAPS PharmSciTech
Quality-by-design-based fabrication of betaxolol hydrochloride-loaded nano-ocular carrier via ternary phase mapping of solid/liquid lipids and BBD modeling for enhanced transcorneal flux andIOP-lowering effect.
  • 15 May 2026
  • AAPS PharmSciTech
Formulation, Optimization and In vivo Evaluation of Freeze-Dried Nanocapsules for Enhancing the Oral Delivery of Valsartan.
  • 13 May 2026
  • AAPS PharmSciTech
Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management.
  • 12 May 2026
  • AAPS PharmSciTech
Safety and Efficacy of Inhaled Natural Product Powders That Enhance Mucociliary Clearance.
  • 15 May 2026
  • AAPS PharmSciTech
Effects of Different Carriers on the Stability and Pharmacokinetic Performance of Cucurbitacin B Solid Dispersions.
  • 15 May 2026
  • AAPS PharmSciTech
In vitro Evaluation of Hydroxypropyl-β-cyclodextrin Effects on Rhein Flux Across Microneedle-pretreated Skin.
  • 15 May 2026
  • AAPS PharmSciTech
Quality-by-design-based fabrication of betaxolol hydrochloride-loaded nano-ocular carrier via ternary phase mapping of solid/liquid lipids and BBD modeling for enhanced transcorneal flux andIOP-lowering effect.
  • 15 May 2026
  • AAPS PharmSciTech
Formulation, Optimization and In vivo Evaluation of Freeze-Dried Nanocapsules for Enhancing the Oral Delivery of Valsartan.
  • 13 May 2026
  • AAPS PharmSciTech
Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management.
  • 12 May 2026
  • AAPS PharmSciTech

FAQs on British Journal of General Practice